deoxyepinephrine has been researched along with Angor Pectoris in 4 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effects of ibopamine on hemodynamic parameters, 9 patients with cardiac dilation after acute myocardial infarction were studied." | 7.68 | Hemodynamic response to ibopamine in acute myocardial infarction. ( Inada, M; Iwasaka, T; Nakamura, S; Onoyama, H; Sugiura, T; Sumimoto, T; Takashima, H; Takayama, Y; Taniguchi, H, 1990) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 7.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 6.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| "To determine the effects of ibopamine on hemodynamic parameters, 9 patients with cardiac dilation after acute myocardial infarction were studied." | 3.68 | Hemodynamic response to ibopamine in acute myocardial infarction. ( Inada, M; Iwasaka, T; Nakamura, S; Onoyama, H; Sugiura, T; Sumimoto, T; Takashima, H; Takayama, Y; Taniguchi, H, 1990) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 3.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 2.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montani, E | 1 |
| Triulzi, MO | 1 |
| Maggi, GC | 1 |
| Sher, D | 2 |
| Licciardello, L | 1 |
| Ferrari, V | 2 |
| Sirtori, F | 1 |
| Cesana, B | 1 |
| Taniguchi, H | 1 |
| Iwasaka, T | 1 |
| Sugiura, T | 1 |
| Takayama, Y | 1 |
| Sumimoto, T | 1 |
| Onoyama, H | 1 |
| Takashima, H | 1 |
| Nakamura, S | 1 |
| Inada, M | 1 |
2 trials available for deoxyepinephrine and Angor Pectoris
| Article | Year |
|---|---|
Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; C | 1991 |
Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Diseases; Deoxyepine | 1987 |
2 other studies available for deoxyepinephrine and Angor Pectoris
| Article | Year |
|---|---|
Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Deoxyepinephrine; Dopamine; Electrocardiography; Heart | 1982 |
Hemodynamic response to ibopamine in acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; He | 1990 |